Browse by author
Lookup NU author(s): Sheila Morgan, Dr Bridget Wilkins
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
We have examined the expression of p75, a member of the TNF receptor superfamily in hepatic stellate cells (HSC) and pancreatic stellate cells (PSC). Activated HSC and PSC were demonstrated by Western blot analysis to express p75. p75 was immunolocalized to cells with a myofibroblast-like morphology in the fibrotic bands of six fibrotic and cirrhotic liver biopsies and three biopsies of fibrotic human pancreas. Immunostaining of parallel sections indicated that these cells were alpha-smooth muscle actin-positive, identifying them as activated HSC and PSC, respectively. HSC apoptosis in tissue culture in the presence of serum was quantified after addition of 0.1 to 100 ng/ml of nerve growth factor (NGF) a ligand for p75, by in situ counting of apoptotic bodies after addition of acridine orange. HSC demonstrated a significant increase in apoptosis in response to 100 ng/ml NGF (0.05 > P by Wilcoxon's rank; n = 7) after 24 hours. NGF 100 ng/ml had no effect on HSC proliferation, but reduced total HSC DNA by 19% relative to control after 24 hours (n = 3). These data demonstrate that activated HSC express p75 and respond to NGF stimulation by undergoing apoptosis. We therefore report p75 as a novel marker of activated HSC and suggest that signaling via ligand binding to p75 may provide a mechanism for selective apoptosis of HSC.
Author(s): Trim N, Morgan S, Evans M, Issa R, Fine D, Afford S, Wilkins BS, Iredale J
Publication type: Article
Publication status: Published
Journal: The American Journal of Pathology
Year: 2000
Volume: 156
Issue: 4
Pages: 1235-1243
ISSN (print): 0002-9440
ISSN (electronic): 1525-2191
Publisher: American Society for Investigative Pathology
URL: http://ajp.amjpathol.org/cgi/content/abstract/156/4/1235
